DECLINE IN THE CD4+ LYMPHOCYTE POPULATION IN THE BLOOD OF SIV-INFECTED MACAQUES IS NOT REFLECTED IN LYMPH-NODES

被引:54
作者
ROSENBERG, YJ
ZACK, PM
WHITE, BD
PAPERMASTER, SF
ELKINS, WR
EDDY, GA
LEWIS, MG
机构
[1] WALTER REED ARMY INST RES,ROCKVILLE,MD 20852
[2] NIAID,BETHESDA,MD 20892
关键词
D O I
10.1089/aid.1993.9.639
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although loss of CD4+ lymphocytes in peripheral blood is a standard criterion for evaluating the course of HIV disease, little is known about changes within lymphoid organs, which contain the bulk (>50%) of the body's lymphocytes. Because such studies are feasible only by using non-human primates, we have examined lymph nodes (LNs), spleen, and blood from monkeys infected with two isolates of simian immunodeficiency virus (SIV). During both the acute and chronic phases of these infections, characteristic reductions in the blood CD4+ cell levels are not reflected in LN, where the CD4+ pool remains within normal levels. However, when circulating CD4/CD8 ratios have consistently fallen to approximately 0.5, striking decreases in the percentage of CD4 cells (CD4%) and CD4/CD8 ratios in LN occur concomitantly with dramatic increases in viral antigen expression on follicular dendritic cells within LN germinal centers (GCs). The data suggest that loss from the total T cell pool in minimal until the final stages of SIV and HIV disease and that the immunological deterioration of LN is the event that precipitates the increased susceptibility to infections and progression to AIDS.
引用
收藏
页码:639 / 646
页数:8
相关论文
共 36 条
[1]  
ARMSTRONG JA, 1984, LANCET, V2, P370
[2]  
BIBERFELD P, 1986, AM J PATHOL, V125, P436
[3]  
BIRX DL, IN PRESS AIDS RES HU
[4]   CD4-PERCENT IS THE BEST PREDICTOR OF DEVELOPMENT OF AIDS IN A COHORT OF HIV-INFECTED HOMOSEXUAL MEN [J].
BURCHAM, J ;
MARMOR, M ;
DUBIN, N ;
TINDALL, B ;
COOPER, DA ;
BERRY, G ;
PENNY, R .
AIDS, 1991, 5 (04) :365-372
[5]  
CHALIFOUX LV, 1984, LAB INVEST, V51, P22
[6]   HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION [J].
CLARK, SJ ;
SAAG, MS ;
DECKER, WD ;
CAMPBELLHILL, S ;
ROBERSON, JL ;
VELDKAMP, PJ ;
KAPPES, JC ;
HAHN, BH ;
SHAW, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :954-960
[7]   TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAAR, ES ;
MOUDGIL, T ;
MEYER, RD ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :961-964
[8]   THE SIMIAN IMMUNODEFICIENCY VIRUSES [J].
DESROSIERS, RC .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :557-578
[9]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[10]  
FENYO EM, 1988, J VIROL, V62, P4414